AliveCor Logo

Unsere Produkte

Kardia 12L

Neu

KardiaMobile 6L
InstantQT
KardiaPro
Kardia EKG-Geräte

Unsere Lösungen

AF-Screening
Datenintegrationslösungen
Gesundheitsdienstleister
BioPharma

Um

Führung
Mission
Klinische Forschung
Newsroom
Shop all Products
Resource Hub
Contact Us
AliveCor Logo
AliveCor Logo
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
    • (855) 338-8800
    • Mission
    • Führung
    • Forschung
    • Karrieren
    • Nachrichtenredaktion
    • Ressourcen-Hub
    • FAQs
    • Benutzerhandbücher
    • Versand
    • Garantie
    • Wiederverkäufer
    • Integration
    • KardiaMobile 6L
    • KardiaMobile
    • KardiaCare
    • International
    • CO2-Reduktionsplan
    • Erklärung zur modernen Sklaverei
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • Datenschutzrichtlinie
  • Sicherheit
  • Einverständniserklärung zur Telemedizin
  • Bedingungen
  • Zugänglichkeit

©2024 AliveCor, Inc. Alle Rechte vorbehalten.

Geh zurück
AliveCor® to Showcase the AliveCor Heart Monitor at the American Heart
SAN FRANCISCO Calif. Chicago Ill. (Booth #932), 27. April 2026

Association Scientific Sessions

SAN FRANCISCO, Calif. and Chicago, Ill. November 16, 2014 (Booth #932) – AliveCor, Inc. announced today its attendance at the American Heart Association Scientific Sessions taking place at McCormick Place in Chicago, Ill. from November 15-19. There will be many opportunities to learn more about the AliveCor Heart Monitor at the conference, including:

  • In-booth presentations and product demonstrations: AliveCor will offer in-booth presentations and product demonstrations on the clinical capabilities of the AliveCor® Heart Monitor and the AliveECG app.
  • Atrial Fibrillation (AF) Detector: Learn more about AliveCor’s new FDA-cleared automated analysis process (algorithm) that instantly detects if patients are experiencing AF through real-time electrocardiogram (ECG) recordings taken on the AliveCor Heart Monitor, so intervention can take place before potentially life-threatening conditions, like strokes, occur.
  • Provider Dashboard: For health professionals with patients using the AliveCor Heart Monitor, we offer the Provider Dashboard, a free web-based application to help review patients’ ECG data. Demos of the dashboard will be available at our booth.
  • Special Discount: During ACC all AliveCor Heart Monitors will be on sale at our booth for a deeply discounted show price.
  • Discuss our Clinical Studies:
    • A study published in the June 2014 issue of Thrombosis and Haemostasis demonstrated feasibility and cost effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: *Nicole Lowres et al. Thrombosis and Haemostasis 2014: 111/6 (June) pp. 1007–1199 *
    • A study published in the May 2014 issue of Australian Family Physician reported findings on iPhone screening by practice nurses and receptionists for atrial fibrillation in general practice: the GP-SEARCH qualitative pilot study: Jessica Orchard et al. Australian Family Physician Volume 43, No.5, May 2014.

Follow the AliveCor Twitter handle, @AliveCor, for real-time updates from the ACC show floor. To schedule a briefing with AliveCor, please contact Rebecca Phillips, rebecca@alivecor.com .

The AliveCor Heart Monitor’s medical grade ECG recordings can also be shared directly with a physician, or sent to a U.S. board-certified cardiologist or a U.S-based cardiac technician through a cloud-based ECG analysis service provided by AliveCor. In as little as 30 minutes users can receive expert reviews of their ECGs directly through the AliveECG app providing a more complete picture of their current heart health.

The AliveCor Heart Monitor can be purchased at www.alivecor.com .

Lassen Sie uns gemeinsam die kardiovaskuläre Versorgung verändern

Wenn Sie als Arbeitgeber oder Kostenträger auf der Suche nach einer umfassenden Unternehmenslösung für die Herzgesundheit sind, kontaktieren Sie uns.